Medication comparison
Ozempic vs Rybelsus
Ozempic and Rybelsus are both prescription medications (GLP-1 receptor agonist vs GLP-1 receptor agonist (oral tablet)) used for Type 2 diabetes. The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.
Affiliate disclosure: we earn commission on signups. Editorial ranking stays independent.
This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.
Top 3 providers prescribing Ozempic or Rybelsus
See full ranking →Sesame Care
#1From $59.00/mo
~4 hr· self-reportedVisit Sesame CareFound
From $99.00/mo
- BBB-A+
Affiliate links — we earn commission on conversions; editorial ranking is independent.
Drug A
Ozempic
semaglutide
GLP-1 receptor agonist
Novo Nordisk
See full overviewDrug B
Rybelsus
semaglutide (oral)
GLP-1 receptor agonist (oral tablet)
Novo Nordisk
See full overviewOverview
| Property | Ozempic | Rybelsus |
|---|---|---|
| Generic name | semaglutide | semaglutide (oral) |
| Drug class | GLP-1 receptor agonist | GLP-1 receptor agonist (oral tablet) |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| Brand names | Ozempic | Rybelsus |
Approved uses
| Property | Ozempic | Rybelsus |
|---|---|---|
| Approved indications | Type 2 diabetes | Type 2 diabetes |
Dosing
| Property | Ozempic | Rybelsus |
|---|---|---|
| Typical dosing | Titrate to 2.0 mg (weekly SC injection) | — |
Side effects & warnings
| Property | Ozempic | Rybelsus |
|---|---|---|
| Top side effects | Nausea (20.3%), Vomiting (9.2%), Diarrhea (8.5%) | — |
| Contraindications | — | — |
| Boxed warning | Yes | No |
Special populations
| Property | Ozempic | Rybelsus |
|---|---|---|
| Pregnancy | C — Discontinue at least 2 months before a planned pregnancy. | — |
Storage
| Property | Ozempic | Rybelsus |
|---|---|---|
| Storage | Refrigerate before first use. After first use, room temperature up to 56 days. Protect from light. | — |
Cost
| Property | Ozempic | Rybelsus |
|---|---|---|
| Avg monthly cost | $935.77 | $1029.00 |
FDA boxed warning
Ozempic: Risk of thyroid C-cell tumors. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Frequently asked
What is the difference between Ozempic and Rybelsus?
Ozempic is semaglutide (GLP-1 receptor agonist) and Rybelsus is semaglutide (oral) (GLP-1 receptor agonist (oral tablet)). They have different active ingredients and slightly different side-effect profiles.
Is Ozempic or Rybelsus more effective for weight loss?
See each drug's clinical-trials section for the registrational outcome data (SURMOUNT for tirzepatide; STEP for semaglutide; SCALE for liraglutide). Average weight loss varies by trial duration, dose ceiling, and adherence.
Can I switch between Ozempic and Rybelsus?
Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide ↔ tirzepatide). Always coordinate with your prescriber before switching.
Other GLP-1 head-to-head comparisons
Compare Ozempic or Rybelsus against another GLP-1
More medication context
Tools and guides that pair with this comparison.
Overview
Ozempic full overview
semaglutide mechanism, dosing, side effects, and pricing.
ReadOverview
Rybelsus full overview
semaglutide (oral) mechanism, dosing, side effects, and pricing.
ReadLive data
GLP-1 shortage tracker
Real-time FDA shortage status by drug and dose.
ReadFree tool
Are you a candidate?
FDA-criteria decision tree, flags contraindications.
ReadFree tool
Prior auth letter generator
Payer-ready PA letter your prescriber can sign.
ReadLive data
12-month price trends
How telehealth provider pricing has moved over the past year.
Read
Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.